Literature DB >> 1969040

Use of pamidronate for multiple myeloma osteolytic lesions.

Z Man, A B Otero, P Rendo, L Barazzutti, J C Sanchez Avalos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1969040     DOI： 10.1016/0140-6736(90)90452-b

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  A Fitton; D McTavish
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 2.  Bisphosphonate treatment of lytic bone metastases.

Authors:  A Lipton; J R Berenson
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

Review 3.  Bone disease in myeloma.

Authors:  J R Berenson
Journal:  Curr Treat Options Oncol       Date:  2001-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.